Plavix Appears To Be Safe During And After Heart Bypass Date: March 28, 2007 Source: Thomas Jefferson University Summary: Heart surgeons don't have to choose between taking a coronary-bypass ...

Analysis of the 64-year-old base-case patient showed that life expectancy and treatment costs in patients treated with clopidogrel plus aspirin were 9.61 QALYs and US$129,300, after the initial ...

Researchers at the Syracuse (N.Y.) Veterans Affairs Medical Center found that the postpolypectomy bleeding rate is significantly higher in patients on uninterrupted clopidogrel therapy with ...

The overall incidence of bleeding in the patients taking clopidogrel is 9.3%; ... (ABPI). Compendium of Data Sheets and Summaries of Product Characteristics 1999–2000 pp. 252–254.

Maximal platelet aggregation (MPA) >50% was noted in 27.6% of all patients at baseline (who were on maintenance clopidogrel therapy), which decreased to 5% at 24 hours with 900 mg LD of clopidogrel.

Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period.

Half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel, according to a new study. Clopidogrel and aspirin are medications routinely prescribed for one to ...

In a separate prespecified analysis, prausgrel patients under age 75 had a decreased risk for multiple recurrent ischemic events (HR, o.85; 95% CI, 0.72-1.00, P=0.04).According to the TRILOGY ...

In both cases, FDA said patients may have trouble metabolizing Plavix, reducing its ability to prevent deadly blood clots. Plavix had global sales of $7.3 billion in 2007.

Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following cerebrovascular stent placement to combat the risk of blood clots (stent-thrombosis) and reclosure of ...